These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24751998)
61. Modern management of uterine fibroids. Levy BS Acta Obstet Gynecol Scand; 2008; 87(8):812-23. PubMed ID: 18607823 [TBL] [Abstract][Full Text] [Related]
62. [French first results using magnetic resonance-guided focused ultrasound for myoma treatment]. Marret H; Bleuzen A; Guérin A; Lauvin-Gaillard MA; Herbreteau D; Patat F; Tranquart F Gynecol Obstet Fertil; 2011 Jan; 39(1):12-20. PubMed ID: 21185759 [TBL] [Abstract][Full Text] [Related]
63. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results. Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252 [TBL] [Abstract][Full Text] [Related]
64. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Istre O Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):735-47. PubMed ID: 18328788 [TBL] [Abstract][Full Text] [Related]
65. Magnetic resonance-guided focused ultrasound surgery. Hudson SB; Stewart EA Clin Obstet Gynecol; 2008 Mar; 51(1):159-66. PubMed ID: 18303510 [TBL] [Abstract][Full Text] [Related]
66. Reduction by 98% in uterine myoma volume associated with significant symptom relief after peripheral treatment with magnetic resonance imaging-guided focused ultrasound surgery. de Melo FC; Diacoyannis L; Moll A; Tovar-Moll F J Minim Invasive Gynecol; 2009; 16(4):501-3. PubMed ID: 19573831 [TBL] [Abstract][Full Text] [Related]
67. Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience. Lyon PC; Rai V; Price N; Shah A; Wu F; Cranston D Ultraschall Med; 2020 Oct; 41(5):550-556. PubMed ID: 31238385 [TBL] [Abstract][Full Text] [Related]
68. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Rabinovici J; Inbar Y; Revel A; Zalel Y; Gomori JM; Itzchak Y; Schiff E; Yagel S Ultrasound Obstet Gynecol; 2007 Oct; 30(5):771-7. PubMed ID: 17899577 [TBL] [Abstract][Full Text] [Related]
69. [Non-invasive thermoablation of symptomatic uterine fibroids with magnetic resonance-guided high-energy ultrasound]. Eckey T; Neumann A; Bohlmann MK; Barkhausen J; Hunold P Radiologe; 2011 Jul; 51(7):610-9. PubMed ID: 21660621 [TBL] [Abstract][Full Text] [Related]
70. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Mindjuk I; Trumm CG; Herzog P; Stahl R; Matzko M Eur Radiol; 2015 May; 25(5):1317-28. PubMed ID: 25510445 [TBL] [Abstract][Full Text] [Related]
71. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial. AbdElmagied AM; Vaughan LE; Weaver AL; Laughlin-Tommaso SK; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Gorny KR; Leppert PC; Lemens MA; Stewart EA Am J Obstet Gynecol; 2016 Sep; 215(3):338.e1-338.e18. PubMed ID: 27073063 [TBL] [Abstract][Full Text] [Related]
72. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Kim YS; Lim HK; Kim JH; Rhim H; Park BK; Keserci B; Köhler MO; Bae DS; Kim BG; Lee JW; Kim TJ; Sokka S; Lee JH Invest Radiol; 2011 Oct; 46(10):639-47. PubMed ID: 21654495 [TBL] [Abstract][Full Text] [Related]
74. The role of magnetic resonance-guided focused ultrasound in fertility-sparing treatment of uterine fibroids-current perspectives. Ciebiera M; Łoziński T Ecancermedicalscience; 2020; 14():1034. PubMed ID: 32419846 [TBL] [Abstract][Full Text] [Related]
75. EMAS position statement: management of uterine fibroids. Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M; Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954 [TBL] [Abstract][Full Text] [Related]
76. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Sandberg EM; Tummers FHMP; Cohen SL; van den Haak L; Dekkers OM; Jansen FW Fertil Steril; 2018 Apr; 109(4):698-707.e1. PubMed ID: 29653718 [TBL] [Abstract][Full Text] [Related]
77. A retrospective study of magnetic resonance-guided focused ultrasound ablation for uterine myoma in Taiwan. Tung SL; Chou TY; Tseng HS; Lee CM Taiwan J Obstet Gynecol; 2016 Oct; 55(5):646-649. PubMed ID: 27751409 [TBL] [Abstract][Full Text] [Related]
78. Uterine fibroid management: from the present to the future. Donnez J; Dolmans MM Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209 [TBL] [Abstract][Full Text] [Related]
79. Review of nonsurgical/minimally invasive treatments for uterine fibroids. van der Kooij SM; Ankum WM; Hehenkamp WJ Curr Opin Obstet Gynecol; 2012 Dec; 24(6):368-75. PubMed ID: 23014141 [TBL] [Abstract][Full Text] [Related]
80. A Modified Bowel Displacement Technique for Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids and Adenomyosis. Lai M; Chen Y; Li H; Li Y; Wu S; Li Z; Zhang Q J Comput Assist Tomogr; 2022 May-Jun 01; 46(3):379-382. PubMed ID: 35405710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]